Valsartan Amlodipine Tablets (Ⅰ) Obtain Registration Approval
Release time:
2023-06-12
News from our newspaper Recently, Jianfeng Pharmaceutical received the Valsartan Amlodipine Tablets (I) "Drug Registration Certificate") approved and issued by the State Drug Administration.
Valsartan and Amlodipine Tablets (I)(specifications: each tablet contains 80mg of valsartan and 5mg of amlodipine) were developed by Novartis Pharmaceuticals (Novartis). They were approved by EMA for listing in the European Union in January 2007, FDA for listing in the United States in June 2007 and approved for listing in China in September 2009. Valsartan amlodipine tablets (I) are used for the treatment of essential hypertension and for patients whose blood pressure cannot be fully controlled by monotherapy. It has been listed in the National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug List (2022) ", classified as Class B; and has been included in the" National Essential Drug List (2018 Edition) ".
Peak Pharmaceutical submitted its registration application to the Drug Evaluation Center of the State Drug Administration on December 16, 2021 and was accepted, and was approved for listing in China on May 19, 2023. The acquisition of Valsartan Amlodipine Tablets (I) "Drug Registration Certificate" this time indicates that Jianfeng Pharmaceutical is qualified to produce and sell the drug, which will further enrich the product range of Jianfeng Pharmaceutical and help to enhance the competitiveness of the company's pharmaceutical business. (Xu Chunliu)
More information
Peak re-listed China's top 100 cement production capacity Daye peak won the "smart factory leader"
On July 11-12, the 2022 China Cement Industry Summit and TOP100 Award Ceremony organized by China Cement Network, an authoritative media of China's cement industry, was held in Hangzhou. Jianfeng Group once again ranked among the top 100 cement clinker production capacity in China.
2022
08-04
On the afternoon of July 12, the party Committee of the group company held a special meeting attended by party Committee members, senior and middle-level management backbones, heads of grass-roots party organizations and all party members of the group headquarters to learn and convey the spirit of the 15th party congress of the communist party of China in Zhejiang province.
2022
07-24
On the morning of July 1, more than 40 members of the group's party committee, party members of various branches of the group headquarters, and party members of subordinate enterprise branches went to the Shuanglong Hydropower Station, the Red Education Base of Jinhua City, to receive party spirit and revolutionary tradition education.
2022
07-14
Vocational skill level identification examination!
On June 16 and 18, the theoretical and practical examinations for the determination of professional skill level in the peak pharmaceutical sector were held successively in Jinxi pharmaceutical factory. The independent identification of vocational skill level includes three occupations (types of work): pharmaceutical preparation worker, chemical inspector and organic synthesis worker, basically covering the main posts in the pharmaceutical sector, with a total of 125 employees signing up for the identification.
2022
06-21
On June 16, the Jianfeng Pharmaceutical Quality Research and Development Party Branch and the Jinhua Vocational Skills Management Service Center Party Branch held a signing ceremony in Jinxi Factory to establish a party building alliance.
2022
06-21
Jinhua Mayor Xing Zhihong to Peak Research
On the afternoon of June 1, Jinhua Mayor Xing Zhihong, Wucheng District Party Committee Secretary Gao Feng, District Mayor Hu Yuxian, and heads of the Municipal Economic and Information Bureau, Development and Reform Bureau and other departments went to the group headquarters to discuss and exchange with the leaders of the group company to understand the development of the enterprise. Solicit opinions and suggestions from enterprises on government work. After understanding the current business situation of the peak, Xing Zhihong pointed out that focus, follow the right path, frontier, steady, is the peak to long-term prosperity of the magic weapon, must continue to adhere.
2022
06-13